日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease

炎症性肠病疾病严重程度指数是预测并发症的有效工具。

期刊:Inflammatory Bowel Diseases
影响因子:4.3
doi:10.1093/ibd/izad294
Swaminathan, Akhilesh; Fulforth, James M; Frampton, Chris M; Borichevsky, Grace M; Mules, Thomas C; Kilpatrick, Kate; Choukour, Myriam; Fields, Peter; Ramkissoon, Resham; Helms, Emily; Hanauer, Stephen B; Leong, Rupert W; Peyrin-Biroulet, Laurent; Siegel, Corey A; Gearry, Richard B
炎症/感染
炎症
发表日期：2024
文献求助 收藏

Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer

人类炎症性肠病相关结直肠癌的基因组和分子改变

期刊:United European Gastroenterology Journal
影响因子:6.7
doi:10.1177/2050640620919254
Muller, Marie; Hansmannel, Franck; Arnone, Djesia; Choukour, Myriam; Ndiaye, Ndeye Coumba; Kokten, Tunay; Houlgatte, Rémi; Peyrin-Biroulet, Laurent
肿瘤
炎症
肠癌
肿瘤免疫
炎症/感染
发表日期：2020
文献求助 收藏

Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low- and High-Mineral-Content Water on the Tablet in Healthy Adults

多替拉韦分散片的相对生物利用度以及低矿物质含量水和高矿物质含量水对健康成年人服用该片剂的影响

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.332
Buchanan, Ann M; Holton, Michael; Conn, Ian; Davies, Mark; Choukour, Mike; Wynne, Brian R
发表日期：2017
文献求助 收藏

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

卡马西平对多替拉韦药代动力学的影响及剂量建议

期刊:European Journal of Clinical Pharmacology
影响因子:2.7
doi:10.1007/s00228-016-2020-6
Song, Ivy; Weller, Steve; Patel, Juhin; Borland, Julie; Wynne, Brian; Choukour, Mike; Jerva, Fred; Piscitelli, Stephen
发表日期：2016
文献求助 收藏

The effect of dolutegravir on the pharmacokinetics of metformin in healthy subjects

多替拉韦对健康受试者二甲双胍药代动力学的影响

期刊:Journal of the International Aids Society
影响因子:4.9
doi:10.7448/IAS.17.4.19584
Zong, Jian; Borland, Julie; Jerva, Fred; Wynne, Brian; Choukour, Mike; Song, Ivy
发表日期：2014
文献求助 收藏